The company aims to establish an ecosystem for cancer researchers to acquire preclinical and failed clinical assets and collaborate with key opinion leaders and a CRO for drug development, utilizing insights from pooled published and purchased unpublished data and AI-enabled applications. The company may participate in other ventures, acquire, exploit, manage, and dispose of real estate and intellectual property rights, establish subsidiaries and branches in Switzerland and abroad, and perform all legal acts that may be necessary or suitable to promote its purpose or the development of group companies. Furthermore, the company may participate directly or indirectly in group financing, in particular by granting loans to its direct or indirect shareholders or other group companies, or by providing guarantees, sureties, or other securities of any kind for their liabilities to third parties, even if such loans or securities are in the exclusive interest of its direct or indirect shareholders or other group companies and are provided free of charge.
Outbound Leads by COHAGA